ELDELIX
DEAD

Serial Number

79373579

Owner

Swiss Rockets AG

Filing Date

May 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ELDELIX Trademark

Serial Number: 79373579

ELDELIX is a trademark filed by Swiss Rockets AG on May 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Swiss Rockets AG (7 trademarks)

Rittergasse 3

Entity Type: 25

Trademark Details

Filing Date

May 17, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical products, in particular for strengthening the immune system, for defense against flu and colds, for recovery after viral infection as well as for preventing thromboses; medical preparations, in particular for strengthening the immune system, for defense against flu and colds, for recovery after viral infection as well as for preventing thromboses; dietetic foods and products for medical use, in particular for strengthening the immune system, for defense against flu and colds, for recovery after viral infection as well as for preventing thromboses; nutritional supplements for medical use, in particular for strengthening the immune system, for defense against flu and colds, for recovery after viral infection as well as for preventing thromboses

Advice and information services with respect to pharmaceutical and medical products

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Feb 14, 2025 DETH
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 19, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 19, 2024 ABN2
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 20, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2023 REPR